RNA45SN5: A Potential Drug Target and Biomarker (G100861532)

Target Name: RNA45SN5

NCBI ID: G100861532

RNA45SN5

Other Name(s): RN45S | RNA45S5 | RNA, 45S pre-ribosomal N5

RNA45SN5: A Potential Drug Target and Biomarker

RNA45SN5 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and expression patterns have caught the attention of researchers, who are exploring its potential role in various diseases. In this article, we will delve into the details of RNA45SN5 and its potential applications as a drug target and biomarker.

The RNA45SN5 molecule

RNA45SN5 is a small non-coding RNA molecule that was first identified in the human brain. It is composed of 45 nucleotides and has a unique structure that consists of a stem-loop and a 5' end. The stem-loop region of RNA45SN5 is the most conserved and is involved in the formation of a double helix. The 5' end of the RNA molecule is a single-base pair that is involved in the formation of a stem-loop.

RNA45SN5 has been observed to be expressed in various tissues and cells, including the brain, heart, and liver. It is also expressed in various cell types, such as neurons and glial cells, which support the development and maintenance of neural tissues. The expression patterns of RNA45SN5 have been shown to be regulated by various factors, including gene expression, DNA methylation, and post-transcriptional modifications.

The potential drug target

RNA45SN5 has been identified as a potential drug target due to its unique structure and expression patterns. One of the reasons for its potential as a drug target is its conserved stem-loop region, which makes it a stable structure that is difficult to modify. Additionally, its expression in various tissues and cell types suggests that it is involved in the development and maintenance of neural tissues, making it an attractive target for drugs that target neurodegenerative diseases.

RNA45SN5 has also been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to be involved in the regulation of various signaling pathways, including TGF-β, NF-kappa-B, and AP-1. Additionally, RNA45SN5 has been shown to play a role in the regulation of cellular gene expression, suggesting that it may be a useful biomarker for the diagnosis and treatment of various diseases.

The potential biomarker

RNA45SN5 has also been identified as a potential biomarker due to its unique expression patterns. The expression of RNA45SN5 has been shown to be regulated by various factors, including gene expression, DNA methylation, and post-transcriptional modifications. This makes it a potential biomarker for the diagnosis and treatment of various diseases.

One of the potential applications of RNA45SN5 as a biomarker is its ability to be used for non-invasive diagnostic tests. The expression of RNA45SN5 can be used to diagnose various diseases, such as neurodegenerative diseases, by measuring the levels of RNA45SN5 in the patient's body. This is in contrast to many existing diagnostic tests, which rely on the detection of specific proteins or genetic mutations.

Another potential application of RNA45SN5 as a biomarker is its ability to be used for early disease detection. The expression of RNA45SN5 has been shown to be regulated by various factors, including gene expression, DNA methylation, and post

Protein Name: RNA, 45S Pre-ribosomal N5

The "RNA45SN5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA45SN5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets